ibl.ai
Paid
Overview
ibl.ai offers an Agentic AI Operating System for healthcare and other sectors, enabling organizations to deploy HIPAA-compliant AI agents for clinical support, coding, and operations on their own servers. The platform emphasizes full code and data ownership, providing a sovereign AI infrastructure for building agents and applications. It is model-agnostic, allowing users to switch between various large language models (LLMs) like Claude, GPT, Gemini, Llama, or open-source options, without vendor lock-in.
ibl.ai can be deployed in the client’s cloud, private VPC, on-premise, or in fully air-gapped environments, as managed SaaS or entirely on their own servers, ensuring regulated teams maintain data within their own environment. The company is family-owned and operated from New York, NY.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Agentic AI Operating System
- 100% self-hosted with private LLMs included
- Full code, data, and model ownership
- Model-agnostic (supports Claude, GPT, Gemini, Llama, open-source)
- Production-ready autonomous agents
- Up to 85% lower cost at scale (no per-seat lock-in)
- Data unification and ontology framework
- Complete audit trails
- Programmable safety rails and PII detection/redaction
- REST API for all platform capabilities
Use Cases
- Clinical documentation and medical coding
- Prior authorization and patient education
- Clinical support and operations
- HR automation in medical schools (recruiting, onboarding, compliance)
- Career services for medical students (residency coaching, CV review)
- AI-native learning management and course creation
What Physicians Need to Know
Evidence Base
ibl.ai emphasizes an evidence-based approach to evaluating learning impact, utilizing both quantitative metrics and qualitative feedback. The platform facilitates extensive data collection, logging every student interaction for analysis. While the provided information focuses on educational applications, it highlights a commitment to data-driven insights and continuous refinement of AI agents based on collected data. For healthcare, ibl.ai focuses on administrative tasks that support clinicians without directly impacting clinical judgment, such as documentation, coding, prior authorization, and patient communication. These agents aim for consistency in applying coding rules and documentation standards, which can be beneficial in audits.
Clinical Validation Studies
While the provided information does not detail specific clinical validation studies for diagnostic or treatment decision support tools, ibl.ai's approach in other sectors, such as medical education, involves tracking metrics like student usage rates, assessment score improvement, persistence rates, and satisfaction. In a healthcare context, AI systems require rigorous clinical validation, including external testing and evaluation of impact on patient outcomes, ideally through randomized clinical trials. ibl.ai's medical coding agent, for instance, supports human validation of every code suggestion before claim submission.
Alert Fatigue Management
For drug interaction checking, AI tools can help reduce alert volume by prioritizing findings based on clinical significance and patient context. The technical work in AI drug interaction checking focuses on suppressing alerts that do not warrant clinician attention for a specific patient. This approach aims to improve attention to serious interactions and provide structured polypharmacy visibility.
Override Rate Data
ibl.ai's approach to AI drug interaction checking involves an initial analysis of current alert volume and override rates to inform the scope of the solution, with the understanding that fewer alerts can improve safety. However, no specific figures on override rate improvement are published, as these depend on the client's current configuration and baseline.
Drug Interaction Checking
ibl.ai offers an AI agent for Medical Coding that supports certified coders, physicians, and billing staff in selecting accurate, guideline-compliant ICD-10-CM/PCS and CPT codes. This agent accelerates code selection and reduces query volume, with every code suggestion requiring human validation. AI-powered drug interaction checking software evaluates medication regimens for interactions, contraindications, duplications, and cumulative risk, prioritizing by severity and patient context to reduce alert volume. These tools function as decision support, with the prescriber and pharmacist retaining the final decision. AI models can analyze large datasets quickly to identify harmful interactions, with some models demonstrating high accuracy in predicting drug-drug interactions.
Differential Diagnosis Support
While ibl.ai's primary focus appears to be on administrative and educational AI agents, AI tools for differential diagnosis can analyze patient symptoms, lab results, and medical history to suggest possible diagnoses ranked by probability. These tools can help clinicians consider conditions they might have missed and identify rare diseases faster. Strong differential diagnosis tools explain their reasoning, cite evidence, and integrate into clinical workflows without replacing physician judgment.
Guideline Update Frequency
ibl.ai's platform updates frequently, with numerous production image and package releases occurring weekly. This suggests a continuous development cycle, which is crucial for keeping AI agents and their underlying knowledge bases current. For medical coding, the agent always cites the Official ICD-10-CM/PCS Guidelines for Coding.
Clinical Workflow Integration
ibl.ai is designed to integrate with existing systems. For medical education, it integrates with learning management systems like Blackboard and Canvas using LTI 1.3 Advantage, providing single sign-on and secure context sharing. In healthcare, ibl.ai agents for tasks like clinical documentation, medical coding, prior authorization, and patient education are designed to integrate directly with hospital affiliate systems and existing SIS. The platform emphasizes that AI activities can 'live inside' existing systems, minimizing workflow disruption.
Decision Audit Trail
ibl.ai provides a comprehensive audit trail for its AI agents, logging every agent action, model call, and decision. This audit trail is designed to be traceable and reviewable, capturing every reasoning step, tool call, and model invocation in a structured, queryable log. This is presented as a foundation for responsible AI deployment, enabling governance, regulatory compliance, incident investigation, and continuous model improvement. The audit logs are written to infrastructure owned and controlled by the client, with options for air-gapped deployment to satisfy data sovereignty requirements. A defensible AI audit trail in healthcare should capture at least 12 fields for every AI-influenced decision, including user identity, AI system and model versions, inputs, reasoning, output, and human review.
Physician Tip
When considering ibl.ai, focus on how its AI agents can streamline administrative burdens like documentation and coding, freeing up more time for direct patient care. Pay close attention to the audit trail capabilities, as these offer transparency into AI-assisted decisions and can be crucial for compliance and accountability. For drug interaction checking, understand that the system aims to reduce alert fatigue by prioritizing critical interactions, but human validation remains essential. As ibl.ai emphasizes client ownership of code and data, this can be a significant advantage for maintaining control over sensitive patient information and customizing the AI to specific clinical needs.
ibl.ai is built as an AI operating system that can be self-hosted on your infrastructure (cloud, VPC, on-premise, or air-gapped) and is model-agnostic, allowing you to use various large language models. It integrates with existing systems through standard protocols like LTI 1.3 for educational platforms (Blackboard, Canvas, Moodle) and can unify diverse systems (SIS, CRM, ERP, EHR) into a single knowledge layer using an MCP interoperability layer. Specific integrations mentioned for healthcare include Epic Fhir, Cerner Fhir, Nuance DAX, Uptodate, Micromedex, Availity, Servicenow, Healthstream, and Pubmed. This architecture allows for deep integration into existing clinical workflows without requiring data extraction to third-party clouds, enhancing data privacy and security.
Details
| Category | Clinical Decision Support & Reference, Developer Tools & APIs, Medical Billing & RCM |
| Pricing |
Paid
|
| Deployment | Client's cloud (AWS, Azure, GCP), private VPC, on-premise data center, GovCloud, fully air-gapped, or ibl.ai managed cloud. |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status | Unknown AI-estimated — unknown |
| Integrations | |
| EHR | Not specified |
| Specialties | Family Medicine, Hospital Medicine, Internal Medicine |
What the Web Says
ibl.ai is generally perceived as a promising AI solution for healthcare, particularly for its ability to automate administrative tasks and improve clinical workflows. Reviewers highlight its potential to reduce physician burnout by streamlining documentation and prior authorizations, allowing more focus on patient care. While the technology is seen as innovative, some concerns exist regarding data privacy, integration complexity, and the learning curve for new users.
Overall: PositiveStrengths
- Automates administrative tasks (e.g., prior authorizations, documentation)
- Reduces physician burnout and improves work-life balance
- Enhances efficiency in clinical workflows
- Potential for significant cost savings in healthcare operations
- Improves accuracy and consistency in medical coding and billing
- Allows physicians to spend more time with patients
Limitations
- Potential concerns regarding data privacy and security of sensitive patient information
- Integration challenges with existing Electronic Health Record (EHR) systems
- Initial learning curve for healthcare professionals to adapt to new AI tools
- Reliance on AI may lead to over-automation and reduced human oversight
- Cost of implementation and ongoing maintenance might be high for smaller practices
- Accuracy of AI outputs needs continuous monitoring and validation
Based on reviews from: Healthcare IT News, TechCrunch, Reddit (r/healthIT, r/medicine), G2, Capterra, Physician blogs and forums
Last updated: 2026-08-24
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate ibl.ai
Press & Coverage
ibl.ai Blog
Healthcare AI Fails at the Information Layer, Not the Model - ibl.ai
This article argues that healthcare AI often fails due to issues at the information layer, not the AI models themselves, emphasizing the need for self-hosted, HIPAA-compliant platforms where PHI remains within the institution's perimeter. It highlights that ibl.ai allows organizations to own all code and data, ensuring PHI processing inside their perimeter and enforcing minimum-necessary standards at query time.
2026-08
ibl.ai Blog
Shadow AI in Healthcare: The Patient Safety Crisis - ibl.ai
This article addresses the patient safety crisis caused by 'shadow AI' in healthcare, where staff use unapproved consumer AI tools with protected health information (PHI). It proposes that the solution is a sanctioned, self-hosted AI platform like ibl.ai, which allows hospitals to own their AI stack and keep PHI within their own infrastructure.
2026-08
EIN Presswire
Syracuse University Reports First-Season Results for Clementine, the ibl.ai Platform It Owns Outright
Syracuse University reported successful first-season results for its Clementine platform, powered by ibl.ai, with 2,038 students asking 8,217 questions in 37 days. The university operates the full ibl.ai stack on its own Google Cloud under a perpetual source-code license.
2026-08
ibl.ai
Decade-Long Compute Bets Face Two Opposite Curves - ibl.ai
This article discusses the challenge of long-term compute commitments in AI, where frontier training costs are rising while fixed capability costs are rapidly falling. ibl.ai positions itself as a model-agnostic platform where users own the code and data, allowing deployment anywhere, including air-gapped environments, without per-seat pricing.
2026-08
ibl.ai Blog
AI Governance for Banks: The 90-Day Framework for 2026 - ibl.ai
This article outlines a 90-day framework for banks to implement AI governance in 2026, aligning with existing regulations like SR 11-7, SEC, and FINRA expectations. It emphasizes that regulators expect generative AI models to be treated like quantitative models, requiring documented inventory, risk tiering, and ongoing monitoring.
2026-05
ibl.ai
MiniMax's 2.7-Trillion-Parameter Model Proves Enterprise AI Must Be Model-Agnostic - ibl.ai
This article highlights the upcoming release of MiniMax's 2.7-trillion-parameter open-source model, arguing that it underscores the necessity for enterprises to adopt model-agnostic AI infrastructure. ibl.ai is presented as a solution for organizations to self-host and adopt new leading models as they emerge, avoiding vendor lock-in.
2026-07
ibl.ai
AI for Compliance & Risk at State University Systems | ibl.ai
This article describes how ibl.ai deploys AI agents to unify regulatory monitoring, audit preparation, and compliance training across state university systems. The platform allows institutions to own all code and data, run it model-agnostic, and deploy anywhere, including air-gapped networks.
2026-03
ibl.ai Blog
When Compliance AI Hallucinates, Who Audits the Filing? - ibl.ai
This article discusses the critical issue of AI hallucinations in compliance filings, emphasizing that auditable AI requires the ability to reconstruct the exact prompt, retrieved context, model version, raw output, and human review for any filing. ibl.ai's platform ensures the entire inference path runs and is recorded within the user's perimeter, making it auditable.
2026-08
Frequently Asked Questions
ibl.ai is designed for self-hosting within your HIPAA-covered environment, meaning protected health information (PHI) never leaves your infrastructure to reach a third-party model. You own all the code and data, and the system can be deployed in your private VPC, on-premise, or even air-gapped, ensuring PHI remains within your control.
ibl.ai offers specialist AI agents for healthcare that can assist with tasks such as ICD-10-CM/PCS and CPT code selection, clinical documentation by drafting structured notes, prior authorization by assembling payer requests, and creating patient education materials at appropriate health literacy levels.
ibl.ai utilizes a flat-rate or usage-based pricing model, eliminating per-seat fees common with other AI platforms like ChatGPT Enterprise or Microsoft Copilot. This means costs track actual usage or ownership rather than headcount, potentially leading to significant savings, especially for larger organizations.
While ibl.ai agents can accelerate tasks like code selection and documentation, every suggestion requires human validation. The system is designed to support clinicians by taking on administrative load without replacing clinical judgment, and physicians need to understand the AI's limitations and ensure appropriate use.
Alternatives exist, including other AI platforms that offer per-seat licensing or vendor-hosted SaaS solutions. ibl.ai differentiates itself by offering full source code ownership, model-agnostic deployment (allowing use of various LLMs), and the ability to self-host, which ensures data privacy and avoids vendor lock-in.
ibl.ai enforces HIPAA's 'minimum necessary' standard by processing PHI within your perimeter and resolving entitlements at query time, meaning access control is applied to what the system may read from the source system, rather than just what it displays. This architectural approach helps ensure PHI is limited to the intended purpose.
Suggest an Edit →
| Last Verified: 2026-08-23 | First Added: 2026-08-23